{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:20:33Z","timestamp":1790277633236,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Foundation Children Cancer Free","award":["KiKa grant 384"],"award-info":[{"award-number":["KiKa grant 384"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glucocorticoids, such as dexamethasone, are essential for treating severe childhood conditions, including cancer, organ transplantation, and inflammatory disorders. However, their long-term use can impair bone development, posing risks to pediatric bone health, which is vital for lifelong skeletal integrity. A mechanistic insight into how glucocorticoids negatively impact bone could improve decision-making in patient care, thereby improving the quality of life for pediatric cancer patients and survivors. In this study, we aimed to elucidate the molecular mechanisms underlying dexamethasone-induced bone toxicity in developing bones using single-cell transcriptomics. We treated skeletally immature C57BL\/6JRj male mice with dexamethasone for 28\u00a0days, and assessed the bone architecture with micro-computed tomography, and characterized bone and bone marrow cells from the femurs using single-cell RNA sequencing. Our findings revealed a marked reduction in osteoblast and chondrocyte cell populations and impaired function of pre-osteoblasts. Additionally, dexamethasone adversely affected B cell subsets, significantly depleting early B cell progenitors while allowing some further developed immature B cells to persist. These cellular changes were accompanied by reduced longitudinal bone growth, compromised bone architecture, and increased bone fragility at the highest doses of dexamethasone. Interestingly, unlike observations in adults, dexamethasone did not enhance osteoclast activity in our model. Overall, our study suggests that the adverse effects of dexamethasone on bone development are primarily due to its impact on osteoblastic, chondroblastic, and B cell lineages. This disruption affects the critical signaling crosstalk between the cells necessary for both bone development and hematopoiesis.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziaf146","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:47:34Z","timestamp":1757159254000},"source":"Crossref","is-referenced-by-count":7,"title":["Mechanisms of dexamethasone-induced bone toxicity in developing bone: a single-cell perspective"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4131-675X","authenticated-orcid":false,"given":"Kelly","family":"Warmink","sequence":"first","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]},{"name":"Department of Orthopaedics, University Medical Center Utrecht , 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7535-583X","authenticated-orcid":false,"given":"Philip","family":"Lijnzaad","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8655-1350","authenticated-orcid":false,"given":"Stephanie A","family":"Schubert","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-881X","authenticated-orcid":false,"given":"Tristan C W","family":"Vermaat","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2863-8211","authenticated-orcid":false,"given":"Lisa","family":"Jansen","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-6846","authenticated-orcid":false,"given":"Marloes C C","family":"van Gend","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Balwierz","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Proost","sequence":"additional","affiliation":[{"name":"Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, Netherlands Cancer Institute , 1066 CX Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6779-9353","authenticated-orcid":false,"given":"Marieke","family":"van de Ven","sequence":"additional","affiliation":[{"name":"Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, Netherlands Cancer Institute , 1066 CX Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7659-1028","authenticated-orcid":false,"given":"Johannes H M","family":"Merks","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-2015","authenticated-orcid":false,"given":"Thanasis","family":"Margaritis","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3307-2559","authenticated-orcid":false,"given":"Claudia Y","family":"Janda","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"2025092810414827400_ref1","doi-asserted-by":"publisher","first-page":"103492","DOI":"10.1016\/j.critrevonc.2021.103492","article-title":"Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia","volume":"168","author":"Velentza","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"S2","key":"2025092810414827400_ref2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/pbc.21407","article-title":"Osteoporosis in children with cancer","volume":"50","author":"van der Sluis","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"2025092810414827400_ref3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bone.2016.01.027","article-title":"Early injury to cortical and cancellous bone from induction chemotherapy for adolescents and young adults treated for acute lymphoblastic leukemia","volume":"85","author":"Orgel","year":"2016","journal-title":"Bone"},{"key":"2025092810414827400_ref4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bone.2013.11.017","article-title":"Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol","volume":"59","author":"Te Winkel","year":"2014","journal-title":"Bone"},{"issue":"8","key":"2025092810414827400_ref5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/jbmr.3447","article-title":"Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study","volume":"33","author":"Ward","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2025092810414827400_ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020444","article-title":"Clinical use and molecular action of corticosteroids in the pediatric age","volume":"20","author":"Ferrara","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2025092810414827400_ref7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4248\/BR201302001","article-title":"Endogenous glucocorticoids and bone","volume":"1","author":"Zhou","year":"2013","journal-title":"Bone Res"},{"key":"2025092810414827400_ref8","doi-asserted-by":"publisher","first-page":"835720","DOI":"10.3389\/fendo.2022.835720","article-title":"Bad to the bone: the effects of therapeutic glucocorticoids on osteoblasts and osteocytes","volume":"13","author":"Gado","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2025092810414827400_ref9","doi-asserted-by":"publisher","first-page":"e832","DOI":"10.1038\/cddis.2013.348","article-title":"Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C\/EBPalpha promoter methylation","volume":"4","author":"Li","year":"2013","journal-title":"Cell Death Dis"},{"issue":"3","key":"2025092810414827400_ref10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/jcp.22392","article-title":"Dexamethasone modulates osteogenesis and adipogenesis with regulation of osterix expression in rat calvaria-derived cells","volume":"226","author":"Mikami","year":"2011","journal-title":"J Cell Physiol"},{"issue":"2","key":"2025092810414827400_ref11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbrc.2008.12.035","article-title":"BMP\/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis","volume":"379","author":"Hayashi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"4934","key":"2025092810414827400_ref12","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.2588000","article-title":"1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene","volume":"246","author":"Morrison","year":"1989","journal-title":"Science"},{"issue":"3","key":"2025092810414827400_ref13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1210\/endo-112-3-931","article-title":"Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae","volume":"112","author":"Canalis","year":"1983","journal-title":"Endocrinology"},{"issue":"4","key":"2025092810414827400_ref14","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"issue":"12","key":"2025092810414827400_ref15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/ard.2003.008839","article-title":"Osteocyte viability with glucocorticoid treatment: relation to histomorphometry","volume":"62","author":"Sambrook","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2025092810414827400_ref16","doi-asserted-by":"publisher","first-page":"E587","DOI":"10.1152\/ajpendo.00219.2016","article-title":"Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice","volume":"311","author":"Piemontese","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"2025092810414827400_ref17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.bone.2005.10.004","article-title":"Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells","volume":"38","author":"Humphrey","year":"2006","journal-title":"Bone"},{"key":"2025092810414827400_ref18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3389\/fendo.2020.00576","article-title":"Glucocorticoid-induced osteoporosis: why kids are different","volume":"11","author":"Ward","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2025092810414827400_ref19","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","article-title":"A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia","volume":"177","author":"Baryawno","year":"2019","journal-title":"Cell"},{"issue":"2","key":"2025092810414827400_ref20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.celrep.2019.06.031","article-title":"Mapping distinct bone marrow niche populations and their differentiation paths","volume":"28","author":"Wolock","year":"2019","journal-title":"Cell Rep"},{"issue":"4","key":"2025092810414827400_ref21","doi-asserted-by":"publisher","first-page":"107158","DOI":"10.1016\/j.jbc.2024.107158","article-title":"Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone","volume":"300","author":"Nookaew","year":"2024","journal-title":"J Biol Chem"},{"issue":"1","key":"2025092810414827400_ref22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2025092810414827400_ref23","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"2025092810414827400_ref24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci"},{"issue":"2","key":"2025092810414827400_ref25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/1759720X09343729","article-title":"Glucocorticoid-induced osteoporosis: treatment update and review","volume":"1","author":"Fraser","year":"2009","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9","key":"2025092810414827400_ref26","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1002\/art.30307","article-title":"Osteoarthritis induction leads to early and temporal subchondral plate porosity in the tibial plateau of mice: an in vivo microfocal computed tomography study","volume":"63","author":"Botter","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2025092810414827400_ref27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cell.2022.12.031","article-title":"Lymphatic vessels in bone support regeneration after injury","volume":"186","author":"Biswas","year":"2023","journal-title":"Cell"},{"key":"2025092810414827400_ref28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jare.2022.01.006","article-title":"Single-cell RNA sequencing analysis reveals the relationship of bone marrow and osteopenia in STZ-induced type 1 diabetic mice","volume":"41","author":"Zhong","year":"2022","journal-title":"J Adv Res"},{"issue":"18","key":"2025092810414827400_ref29","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.cub.2014.07.077","article-title":"Histone H3.3 is required to maintain replication fork progression after UV damage","volume":"24","author":"Frey","year":"2014","journal-title":"Curr Biol"},{"issue":"8","key":"2025092810414827400_ref30","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/ni.2641","article-title":"Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells","volume":"14","author":"Nechanitzky","year":"2013","journal-title":"Nat Immunol"},{"issue":"1","key":"2025092810414827400_ref31","doi-asserted-by":"publisher","first-page":"e0170261","DOI":"10.1371\/journal.pone.0170261","article-title":"Leucine rich alpha-2 glycoprotein: a novel neutrophil granule protein and modulator of myelopoiesis","volume":"12","author":"Druhan","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2025092810414827400_ref32","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1530\/JOE-17-0361","article-title":"Animal models to explore the effects of glucocorticoids on skeletal growth and structure","volume":"236","author":"Wood","year":"2018","journal-title":"J Endocrinol"},{"key":"2025092810414827400_ref33","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/bonekey.2014.47","article-title":"Instructions for producing a mouse model of glucocorticoid-induced osteoporosis","volume":"3","author":"Thiele","year":"2014","journal-title":"Bonekey Rep"},{"key":"2025092810414827400_ref34","volume-title":"Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications","author":"Devogelaer","year":"2017"},{"issue":"1","key":"2025092810414827400_ref35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/jbmr.5650030117","article-title":"Effect of short-term glucocorticoids on serum osteocalcin in healthy young men","volume":"3","author":"Godschalk","year":"1988","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2025092810414827400_ref36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metab"},{"issue":"6","key":"2025092810414827400_ref37","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/art.23454","article-title":"Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025092810414827400_ref38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.steroids.2016.10.008","article-title":"Continuous corticosterone delivery via the drinking water or pellet implantation: a comparative study in mice","volume":"116","author":"Gasparini","year":"2016","journal-title":"Steroids"},{"issue":"1","key":"2025092810414827400_ref39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00198-015-3308-6","article-title":"Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength","volume":"27","author":"Yao","year":"2016","journal-title":"Osteoporos Int"},{"issue":"3","key":"2025092810414827400_ref40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/endrev\/bnac031","article-title":"Bone turnover markers: basic biology to clinical applications","volume":"44","author":"Schini","year":"2023","journal-title":"Endocr Rev"},{"issue":"2","key":"2025092810414827400_ref41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review 1: bisphosphonate use in childhood osteoporosis","volume":"94","author":"Bachrach","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025092810414827400_ref42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40200-014-0109-y","article-title":"Bisphosphonate therapy in pediatric patients","volume":"13","author":"Eghbali-Fatourechi","year":"2014","journal-title":"J Diabetes Metab Disord"},{"key":"2025092810414827400_ref43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eclinm.2019.07.002","article-title":"Bisphosphonates for prevention of bone loss in glucocorticoid-treated young people","volume":"12","author":"Reid","year":"2019","journal-title":"EClinicalMedicine"},{"key":"2025092810414827400_ref44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.eclinm.2019.06.004","article-title":"The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: a randomised double-blind controlled trial","volume":"12","author":"Rooney","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"4","key":"2025092810414827400_ref45","doi-asserted-by":"publisher","first-page":"CD005324","DOI":"10.1002\/14651858.CD005324.pub2","article-title":"Bisphosphonate therapy for children and adolescents with secondary osteoporosis","volume":"2007","author":"Ward","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2025092810414827400_ref46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/intimm\/dxh230","article-title":"Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids","volume":"17","author":"Igarashi","year":"2005","journal-title":"Int Immunol"},{"issue":"2","key":"2025092810414827400_ref47","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/en.2013-1473","article-title":"Analysis of glucocorticoid receptors and their apoptotic response to dexamethasone in male murine B cells during development","volume":"155","author":"Gruver-Yates","year":"2014","journal-title":"Endocrinology."},{"issue":"4","key":"2025092810414827400_ref48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11899-024-00735-w","article-title":"Glucocorticoid therapy in acute lymphoblastic leukemia: navigating short-term and long-term effects and optimal regimen selection","volume":"19","author":"Pourhassan","year":"2024","journal-title":"Curr Hematol Malig Rep"},{"key":"2025092810414827400_ref49","doi-asserted-by":"publisher","first-page":"116296","DOI":"10.1016\/j.bone.2021.116296","article-title":"Interactions of B-lymphocytes and bone cells in health and disease","volume":"168","author":"Grcevic","year":"2023","journal-title":"Bone"},{"issue":"3","key":"2025092810414827400_ref50","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bone.2010.06.011","article-title":"How B cells influence bone biology in health and disease","volume":"47","author":"Horowitz","year":"2010","journal-title":"Bone"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziaf146\/64220098\/ziaf146.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/10\/ziaf146\/64220098\/ziaf146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/10\/ziaf146\/64220098\/ziaf146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T14:41:56Z","timestamp":1759070516000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziaf146\/8249042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf146","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.13.632523","asserted-by":"object"}]},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,3]]},"article-number":"ziaf146"}}